131 related articles for article (PubMed ID: 8615657)
1. Endometrial cancer cell lines are sensitive to paclitaxel.
Rantanen V; Grénman S; Kulmala J; Grénman R
Anticancer Res; 1996; 16(1):475-9. PubMed ID: 8615657
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel and cisplatin sensitivity of ovarian carcinoma cell lines tested with the 96-well plate clonogenic assay.
Engblom P; Rantanen V; Kulmala J; Grènman S
Anticancer Res; 1996; 16(4A):1743-7. PubMed ID: 8712694
[TBL] [Abstract][Full Text] [Related]
3. Vulvar squamous cell carcinoma cell lines are sensitive to paclitaxel in vitro.
Jaakkola M; Rantanen V; Grénman S; Kulmala J; Grénman R
Anticancer Res; 1997; 17(2A):939-43. PubMed ID: 9137431
[TBL] [Abstract][Full Text] [Related]
4. Taxane sensitivity of ovarian carcinoma in vitro.
Engblom P; Rantanen V; Kulmala J; Heiskanen J; Grenman S
Anticancer Res; 1997; 17(4A):2475-9. PubMed ID: 9252666
[TBL] [Abstract][Full Text] [Related]
5. Potential use of the adenosine triphosphate cell viability assay in endometrial cancer.
Tam KF; Ng TY; Tsang PC; Li CF; Ngan HY
J Soc Gynecol Investig; 2006 Oct; 13(7):518-22. PubMed ID: 16979354
[TBL] [Abstract][Full Text] [Related]
6. Placental leucine aminopeptidase (P-LAP) expression is associated with chemosensitivity in human endometrial carcinoma.
Shibata K; Kikkawa F; Kondo C; Mizokami Y; Kajiyama H; Ino K; Nomura S; Mizutani S
Gynecol Oncol; 2004 Nov; 95(2):307-13. PubMed ID: 15491750
[TBL] [Abstract][Full Text] [Related]
7. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
Xiao Y; Li JD; Shi HL; Liu JH; Feng YL; Li MD
Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657
[TBL] [Abstract][Full Text] [Related]
8. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree IA; Hepp H; Untch M
Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel and radiotherapy: sequence-dependent efficacy--a preclinical model.
Niero A; Emiliani E; Monti G; Pironi F; Turci L; Valenti AM; Marangolo M
Clin Cancer Res; 1999 Aug; 5(8):2213-22. PubMed ID: 10473108
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel/carboplatin versus cyclophosphamide/adriamycin/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma.
Hidaka T; Nakamura T; Shima T; Yuki H; Saito S
J Obstet Gynaecol Res; 2006 Jun; 32(3):330-7. PubMed ID: 16764625
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.
O'Meara AT; Sevin BU
Gynecol Oncol; 2001 Nov; 83(2):334-42. PubMed ID: 11606094
[TBL] [Abstract][Full Text] [Related]
12. Persistent chemosensitivity to platinum and/or paclitaxel in metastatic endometrial cancer.
Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
Gynecol Oncol; 1999 Jun; 73(3):422-3. PubMed ID: 10366471
[TBL] [Abstract][Full Text] [Related]
13. [Chemosensitivity test for 170 human breast carcinoma samples].
He Z; Yuan J; Chen Z; Liu S; Shen Z; Fei H
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):531-4. PubMed ID: 10806759
[TBL] [Abstract][Full Text] [Related]
14. Head and neck carcinoma cell lines are sensitive to vinflunine in vitro.
Erjala K; Raitanen M; Kulmala J; Grénman R
Anticancer Res; 2005; 25(6B):4363-7. PubMed ID: 16309241
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
[TBL] [Abstract][Full Text] [Related]
16. [Dose response curve of paclitaxel measured by histoculture drug response assay].
Yoshimasu T; Oura S; Hirai I; Kokawa Y; Okamura Y; Furukawa T
Gan To Kagaku Ryoho; 2005 Apr; 32(4):497-500. PubMed ID: 15853216
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients.
Sonnemann J; Gänge J; Pilz S; Stötzer C; Ohlinger R; Belau A; Lorenz G; Beck JF
BMC Cancer; 2006 Jul; 6():183. PubMed ID: 16834771
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
[TBL] [Abstract][Full Text] [Related]
19. In vitro chemosensitivity testing of human non-small cell lung cancer cell lines.
Bepler G; O'Briant K
Anticancer Res; 1998; 18(5A):3181-5. PubMed ID: 9858881
[TBL] [Abstract][Full Text] [Related]
20. Head and neck squamous cell carcinoma is highly sensitive to vinorelbine in Vitro.
Erjala K; Pulkkinen J; Kulmala J; Alanen K; Grenman R
Anticancer Res; 2002; 22(6A):3135-42. PubMed ID: 12530056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
